Role of colony‐stimulating factors in the biology of acute myelogenous leukemia
Authors:
- 2 January 1989
- journal article
- review article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 7 (1) , 13-29
Abstract
A high proportion of acute myeloid leukemias (AML) recently investigated for their capacity to synthesize biologically active bioregulatory molecules was found to accumulate messenger (m) RNA and to produce membrane‐bound or ‐secreted forms of stimulating factors for granulocyte, macrophage and mixed granulocyte‐macrophage colony growth. Blast cells have also been found to secrete interleukin 1, tumor necrosis factor‐alpha, interleukin 6, and to express receptors for various growth factors as well. However, growth factors like interleukin 2 and interleukin 3 have not been identified as AML products, and several other factors including interleukin 4, interleukin 5, etc. need further evaluation. Responsiveness of clonogenic leukemic cells to exogenous growth‐promoting factors in vitro suggests a possible role of these biomolecules in the course of these disorders. Important evidence for the crucial role of growth factors, at least in some subtypes of AML, has been provided by demonstrating constitutive growth factor production by leukemic cells and their autonomous in vitro growth which is dependent on autocrine secretion of a specific growth factor. The concert of mechanisms providing stimulatory and inhibitory signals for hematopoiesis, which is adapted to the various physiological requirements of the organism, may have multiple defects in AML. This leads to successive steps of malfunctioning of cells, which finally express a fully malignant phenotype. In addition, these derangements also lead to defects in accessory cells on the level of mediator communication. However, there is evidence for autonomous growth promotion of AML blast by constitutive production of growth factors active in an autocrine fashion (GM‐CSF, G‐CSF, interleukin 6) and by recruitment of accessory cells to increase CSF supply (GM‐CSF, G‐CSF) via molecules such as interleukin 1 and TNF‐alpha in a paracrine fashion. Molecular analysis of transformed hematopoietic cells has revealed changes of the genome, e.g., insertion of viral genetic information or cytogenetic fractures at DNA sites controlling growth factor gene activation. These events appear to be crucial in the induction of uncontrolled growth factor expression promoting oncogenic transformation of hematopoietic progenitor cells.Keywords
This publication has 99 references indexed in Scilit:
- Translocation and Rearrangement of Myeloperoxidase Gene in Acute Promyelocytic LeukemiaScience, 1988
- Interleukin 1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor.Journal of Clinical Investigation, 1988
- Recombinant human granulocyte‐macrophage colony‐stimulating factor induces secretion of autoinhibitory monokines by U‐937 cellsEuropean Journal of Immunology, 1988
- Autocrine stimulation of interleukin 1 beta in acute myelogenous leukemia cells.Journal of Experimental Medicine, 1987
- Hematopoietic growth factors.Journal of Clinical Investigation, 1987
- Interleukin 1 induces cultured human endothelial cell production of granulocyte-macrophage colony-stimulating factor.Journal of Clinical Investigation, 1987
- Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanismCell, 1985
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980
- Colony formation in vitro by leukaemic cells in acute myelogenous leukaemia with phytohaemagglutinin as stimulating factorNature, 1976
- Control of growth of mammalian cells in cell cultureNature, 1975